Oncology & Cancer

Stage III/IV melanoma patients at risk for new primaries

(HealthDay)—Patients with stage III or IV melanoma who have not received treatment with BRAF inhibitors remain at risk for developing new primary melanomas (NPMs), although the incidence rates are lower than those observed ...

Oncology & Cancer

Journal retracts controversial GMO cancer study

The journal Food and Chemical Toxicology is retracting a highly controversial French study it published last year linking genetically modified maize to cancerous tumors in rats.

Diseases, Conditions, Syndromes

Spatiotemporal analysis emphasizes value of vaccination

(HealthDay)—Spatiotemporal data emphasizes the importance of vaccination programs, according to research published in the Nov. 28 issue of the New England Journal of Medicine.

Oncology & Cancer

Cancer trends tell tale of insufficient prevention

Australians are now developing cancer at slightly higher rates but dying of the disease less often, according to University of Sydney research published in the Medical Journal of Australia (MJA).

Diseases, Conditions, Syndromes

Fewer cases of antibiotic-resistant MRSA infection in the US in 2011

An estimated 30,800 fewer invasive methicillin-resistant Staphylococcus aureus (MRSA) infections occurred in the United States in 2011 compared to 2005, according to a study in JAMA Internal Medicine by Raymund Dantes, M.D., ...

page 36 from 40